| scholarly article | Q13442814 |
| P2093 | author name string | Hari Dandapantula | |
| Evan Hardegree | |||
| Janet Massey | |||
| Philip Houck | |||
| P2860 | cites work | 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines | Q22306358 |
| Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study | Q28167204 | ||
| Angiotensin-neprilysin inhibition versus enalapril in heart failure | Q28247091 | ||
| Combination of isosorbide dinitrate and hydralazine in blacks with heart failure | Q28292266 | ||
| The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators | Q28372091 | ||
| Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial | Q34003169 | ||
| The effect of cardiac resynchronization on morbidity and mortality in heart failure | Q34400885 | ||
| Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. | Q34575166 | ||
| Calorie restriction and aging: review of the literature and implications for studies in humans | Q35205620 | ||
| Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure | Q36655484 | ||
| Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods | Q36743923 | ||
| Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. | Q36891117 | ||
| Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial | Q37181288 | ||
| Anemia and mortality in heart failure patients a systematic review and meta-analysis | Q37255449 | ||
| The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results | Q37312814 | ||
| Potential impact of optimal implementation of evidence-based heart failure therapies on mortality | Q37884919 | ||
| Hydralazine and nitrates alone or combined for the management of chronic heart failure: A systematic review. | Q38527446 | ||
| Lymphatic pumping: mechanics, mechanisms and malfunction. | Q38843093 | ||
| Prevalence and Predictors of Sleep-Disordered Breathing in Patients With Stable Chronic Heart Failure: The SchlaHF Registry | Q40196112 | ||
| Ventricular interdependence: Significant left ventricular contributions to right ventricular systolic function | Q41693575 | ||
| Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators | Q44239425 | ||
| Continuous ultrafiltration for congestive heart failure: the CUORE trial. | Q44870202 | ||
| In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). | Q46578814 | ||
| Acute decompensated heart failure: the shrinking role of inotropic therapy | Q46578817 | ||
| Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation | Q46624550 | ||
| Right ventricular myocardium derives from the anterior heart field | Q47290410 | ||
| Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment | Q47889164 | ||
| Molecular and functional analyses of the contractile apparatus in lymphatic muscle | Q47999196 | ||
| Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure | Q48801339 | ||
| Impact of Type 2 Myocardial Infarction (MI) on Hospital-Level MI Outcomes: Implications for Quality and Public Reporting. | Q55003508 | ||
| The trouble with troponin. | Q55434159 | ||
| Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction | Q57396237 | ||
| The effect of digoxin on mortality and morbidity in patients with heart failure | Q73080377 | ||
| Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials | Q77313148 | ||
| Influence of left bundle branch block on long-term mortality in a population with heart failure | Q80725166 | ||
| Heart Failure in Patients with Diabetes Mellitus | Q88711798 | ||
| Effect of Influenza on Outcomes in Patients With Heart Failure | Q90903305 | ||
| P433 | issue | 6 | |
| P304 | page(s) | e8930 | |
| P577 | publication date | 2020-06-30 | |
| P1433 | published in | Cureus | Q27725810 |
| P1476 | title | Why We Fail at Heart Failure: Lymphatic Insufficiency Is Disregarded | |
| P478 | volume | 12 |
Search more.